Anti-CRISPR Proteins Project
Overview
This project tracks the annotation review of anti-CRISPR (Acr) proteins - phage-encoded inhibitors of bacterial CRISPR-Cas immune systems. These proteins represent a fascinating example of evolutionary arms race between bacteria and their viral predators, and present unique challenges for GO annotation:
- Novel molecular mechanisms - Acr proteins often have unique mechanisms not well-captured by existing GO terms
- Dual-targeting strategies - Some Acrs interact with both protein and RNA components
- Regulatory complexity - Expression is tightly regulated via Aca (anti-CRISPR associated) repressors
- Sparse annotations - Many Acr proteins have only generic IEA annotations
These proteins are excellent targets for AI-assisted curation because their mechanisms are well-studied structurally but annotations lag behind.
Source: Presented at Gene Ontology Consortium Meeting, October 2025, Cambridge UK. See ai4curation/ai-gene-review.
Key Concepts
Anti-CRISPR Mechanisms
- Type I-F inhibitors (AcrIF family) - Target Csy surveillance complex
- Type I-E inhibitors (AcrIE family) - Target Cascade complex
- Type II inhibitors (AcrIIA/IIC) - Target Cas9/Cas12
- Type III inhibitors - Target Csm/Cmr complexes
Inhibition Strategies
- Blocking DNA recognition
- Preventing R-loop formation
- Mimicking DNA substrates
- Direct crRNA binding (unique mechanism)
- Enzymatic inactivation
Featured Examples
AcrF8 (Pectobacterium phage ZF40)
Organism: BPZF4 (bacteriophage)
UniProt: H9C181
Status: COMPLETE
Key Findings:
- 92-amino acid protein that inhibits Type I-F CRISPR-Cas system
- Unique dual-targeting mechanism: binds BOTH Cas7f protein backbone AND crRNA scaffold
- Contacts nucleotides U[+21], U[+22], G[+23] of crRNA at <4Å distance
- Blocks R-loop formation and prevents target DNA recognition
- Cryo-EM structure at 3.42Å resolution (PMID:32170016)
Annotation Issues Identified:
- GO:0052170 (symbiont-mediated suppression of host innate immune response) - Too general
- Action: MODIFY → GO:0098672 (symbiont-mediated suppression of host CRISPR-cas system)
- Missing core function annotation for ribonucleoprotein complex binding
Proposed New GO Term:
- Name: CRISPR RNA binding anti-CRISPR activity
- Justification: Current terms don't distinguish between Acrs that only bind Cas proteins vs. those that directly contact crRNA. AcrF8 represents a unique class with dual protein-RNA binding.
Genes for Review
Priority 1: Structurally Characterized Acrs
| Species | Gene | CRISPR Type | Status |
|---|---|---|---|
| BPZF4 | AcrF8 | Type I-F | COMPLETE |
Priority 2: Other Acr Families
(To be identified - AcrIF, AcrIE, AcrIIA families)
Priority 3: Aca Regulators
(Anti-CRISPR associated proteins that regulate Acr expression)
Key Mechanisms to Annotate
- Surveillance complex binding -
GO:0043021ribonucleoprotein complex binding - CRISPR-Cas suppression -
GO:0098672symbiont-mediated suppression of host CRISPR-cas system - DNA mimic function - Where Acrs structurally mimic DNA
- crRNA binding - Direct RNA contacts (needs new term?)
Key References
- Bondy-Denomy J et al. (2013) Nature - Anti-CRISPR discovery
- Pawluk A et al. (2016) Cell - AcrIF mechanisms
- Wang J et al. (2020) Nat Commun - AcrF8/F9/F6 cryo-EM structures (PMID:32170016)
- Stanley SY et al. (2019) Cell - Aca repressor mechanisms (PMID:31474367)
Related Projects
- Phage-host interactions
- Bacterial immune systems
STATUS
Completed Reviews
- [x] BPZF4/AcrF8 - Type I-F inhibitor with dual protein-RNA binding
Pending
- [ ] Identify additional Acr proteins in UniProt/QuickGO
- [ ] Review Aca regulator annotations
- [ ] Propose new GO terms for crRNA-binding mechanisms
Last updated: 2026-01-22
NOTES
2026-01-22
Project Creation
Created project to track anti-CRISPR protein annotations.
AcrF8 Highlights:
- Unique dual-targeting: binds both Cas7f protein AND crRNA directly
- Cryo-EM structure shows <4Å contacts with crRNA nucleotides
- Expression regulated by Aca2 repressor in negative feedback loop
- Proposed new GO term for crRNA-binding anti-CRISPR mechanism
The AcrF8 example demonstrates:
1. Need for more specific GO terms for CRISPR-Cas inhibition mechanisms
2. Value of structural biology in informing function annotations
3. Importance of distinguishing protein-only vs. protein+RNA binding mechanisms